Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Events
Search Results - Events
Search
Search
Asset Entries
Any Asset
Time
Any Time
Past Hour
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range…
From
To
Search
No results were found that matched the keywords:
25 maggio 2021
.
Search
Press Release N°36/
2021
COVID-19: The vaccine affords up to 100% protection against
Web Content Article
If the prescribed doses are completed, the vaccine against COVID-19 is approximately 80% effective in protecting against infection and up to 100%
Newsroom:
Special on COVID-19
Press releases
Special on COVID-19 » Vaccini
Press Release N° 29/
2021
First National Study on the impact of COVID-19 vaccine:
Web Content Article
27 December 2020 (date when the vaccination campaign started in Italy) to 3 May
2021
Newsroom:
Special on COVID-19
Press releases
Press Release N°37/
2021
COVID-19: in Italy with over 90% of cases, the 'Delta variant
Web Content Article
In Italy, as at 20 July, the prevalence of the so-called 'Delta variant' of the SARS-CoV-2 virus was 94.8%, a sharp increase compared to the survey of 22 June
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
COVID-19: data from the ISS flash survey in wastewaters confirm prevalence of the Delta variant in Italy
Web Content Article
ISS, September 8th
2021
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
4 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 25 to 28 of 255 entries.
Previous Page
Page
1
...
Intermediate Pages Use TAB to navigate.
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
...
Intermediate Pages Use TAB to navigate.
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
Page
24
Page
25
Page
26
Page
27
Page
28
Page
64
Next Page
Hidden